FDA Adverse Event Death Summary report: N

TALENT ABDOMINAL STENT GRAFT SYSTEM

MDR report key: 2535453 · Received April 13, 2012

Report

Report Number
2953200-2012-00786
Event Type
Death
Date Received
April 13, 2012
Report Date
March 20, 2012
Manufacturer
MEDTRONIC CARDIOVASCULAR SANTA ROSA
Product Code
MIH
PMA / PMN Number
P070027
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION RESULTS: INHERENT RISK OF PROCEDURE (DEATH, ENDOLEAK, RUPTURE, RENAL FAILURE, MI), PATIENT'S CONDITION AFFECTED EFFECTIVENESS OF DEVICE (LIKELY ANATOMY RELATED). EVALUATION . CONCLUSION: DEVICE FAILURE/LACK OF EFFECTIVENESS RELATED TO PATIENT CONDITION (LIKELY ANATOMY RELATED).

Description of Event or Problem · 1

MEDTRONIC RECEIVED THE FOLLOWING INFORMATION OBTAINED FROM THE JOURNAL ARTICLE WHICH IS SUMMARIZED AS FOLLOWS: GENDER-RELATED DIFFERENCES IN INFRARENAL AORTIC ANEURYSM MORPHOLOGIC FEATURES: ISSUES RELEVANT TO ANCURE AND TALENT ENDOGRAFTS VELAZQUES ET AL. J VASC SURG 2001;33:S77-84. THE TOTAL NUMBER OF PATIENTS HAVING UNDERGONE EVAR WERE 88 (N=88). MAJOR ADVERSE EVENTS INCLUDED: UNPLANNED CONVERSION TO OPEN SURGICAL REPAIR (1), ILIAC ARTERY RUPTURE (2), UNABLE TO ACCESS/ABORTED CASE (1), ANCHORING SITE ENDOLEAKS (2). PERIOPERATIVE MORBIDITY AND DEATH WERE ASSOCIATED WITH PNEUMONIA (1), MYOCARDIAL INFARCTION (1), RENAL FAILURE (1), AND INPATIENT PERIOPERATIVE DEATH(S) (4). THE 2 ILIAC RUPTURES WERE RELATED TO OVERLY AGGRESSIVE BALLOONING AT THE DISTAL FIXATION POINT OF TALENT GRAFTS WITH UNCOVERED BARE SPRINGS AS THE DISTAL FIXATION. BOTH OF THESE PATIENTS WERE TREATED WITH AN IMMEDIATE ENDOVASCULAR PLACEMENT OF A LIMB EXTENSION. BOTH OF THESE PATIENTS DID WELL IN THE PERIOPERATIVE PERIOD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TALENT ABDOMINAL STENT GRAFT SYSTEM SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC CARDIOVASCULAR SANTA ROSA

Patients

Seq Age Sex Outcome Treatment
1